Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opko Health Inc (NQ: OPK )

1.485 -0.005 (-0.34%)
Streaming Delayed Price Updated: 10:00 AM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Opko Health Inc

TechMediaBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China
Via Investor Brand Network
2 penny stocks insiders are buying
Penny stocks come with outsized risks, but some risks can be mitigated by following the insiders. Insiders aren't going to waste good money on a bad company. 
Via MarketBeat
These are the 4 hottest stocks insiders bought in January
Insiders are buying these stocks, but not all are good buys for investors or bullish traders; avoid stocks with high short interest, no revenue, and no earnings 
Via MarketBeat
NextPlat latest financial numbers shows double-digit growth in e-commerce and healthcare division
Charlie Fernandez, CEO of NextPlat, provided an update on the company's latest financial results during an interview with Steve Darling from Proactive. 
Via TheNewswire.com
BioMedNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront
Via Investor Brand Network
NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global
Via ACCESSWIRE
MarketBeat Week in Review – 7/17 - 7/21
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
OPKO Health is the Little Giant of Diversified Healthcare
Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential may 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies
Palm Beach, FL – November 7, 2022 – FinancialNewsMedia.com News Commentary – While there is no cure for pancreatic cancer in the pancreatic cancer treatment market, new treatment options abound, and... 
Via FinancialNewsMedia
Exposures COVID-19
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From OPKO Health, Inc.
Via Business Wire
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
From Rite Aid Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.